Cell proliferation, migration, cell cycle alteration, and phenotypic transformation are the main PASMCs mechanisms underlying pulmonary vascular remodeling in PAH.[34, 35, 36] We identify that reduced irisin expression may negatively correlate with the proliferation of PASMCs. The gene discussed is FNDC5; the disease is pulmonary arterial hypertension.